Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma
- Conditions
- Interventions
- First Posted Date
- 2020-09-18
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT04555551
- Locations
- 🇺🇸
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison, New York, United States
Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 16
- Registration Number
- NCT04552990
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies
- Conditions
- Interventions
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT04552288
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center Suffolk - Hauppauge (Limited Protocol Activities), Hauppauge, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
Safety of Lung Cryobiopsy in People With Cancer
- First Posted Date
- 2020-09-16
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 100
- Registration Number
- NCT04548830
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
Neurocutaneous Melanocytosis Registry
- First Posted Date
- 2020-09-16
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 75
- Registration Number
- NCT04548817
- Locations
- 🇺🇸
Boston Children's Hospital (Data Analysis Only), Boston, Massachusetts, United States
🇺🇸Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver
- Conditions
- Interventions
- First Posted Date
- 2020-09-10
- Last Posted Date
- 2024-05-02
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT04544098
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
- First Posted Date
- 2020-09-10
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 19
- Registration Number
- NCT04544111
- Locations
- 🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States
Psychotherapy Intervention for Latinos With Adv Cancer
- Conditions
- Interventions
- First Posted Date
- 2020-09-03
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 285
- Registration Number
- NCT04537936
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸MSK at Ralph Lauren, New York, New York, United States
🇺🇸Lincoln Medical and Mental Health Center, Bronx, New York, United States
ZW25 in Women With Endometrial Cancers
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 16
- Registration Number
- NCT04513665
- Locations
- 🇺🇸
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge, New Jersey, United States
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
- First Posted Date
- 2020-08-13
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 6
- Registration Number
- NCT04512716
- Locations
- 🇺🇸
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
🇺🇸Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre, New York, United States